Yttrium 90
Radioembolisation with yttrium‒90 microspheres versus sorafenib for treatment of advanced hepatocellular carcinoma (SARAH): study protocol for a randomised controlled trial
... β-emitter yttrium-90, is one potential alternative treatment of advanced ...to yttrium‐90 RE in HCC pa- tients ...receiving yttrium‐90 RE report median OS be- tween 7 and ...
8
The effect of selective internal radiation therapy with yttrium-90 resin microspheres on lung carbon monoxide diffusion capacity
... Background: Selective internal radiation therapy (SIRT) with embolization of branches of the hepatic artery is a valuable therapeutic tool for patients with hepatic malignancies; however, it is also associated with lung ...
7
Multi institutional quantitative phantom study of yttrium-90 PET in PET/MRI: the MR-QUEST study
... ( 90 Y) radioembolization involves the intra-arterial delivery of radioactive microspheres to primary or metastatic disease in the ...liver. 90 Y decays primarily with β − emission (mean ...then, 90 ...
18
Personalized predictive lung dosimetry by technetium-99m macroaggregated albumin SPECT/CT for yttrium-90 radioembolization
... using yttrium-90 ( 90 Y) resin (SIR-Spheres®, Sirtex Medical Limited, North Sydney, New South Wales, Australia) or glass (TheraSphere®, BTG, Ottawa, Ontario, Canada) microspheres for the treatment of ...
12
A Woman with Black Beads in Her Stomach: Severe Gastric Ulceration Caused by Yttrium-90 Radioembolization
... to yttrium-90 ( 90 Y) seed migration to the stomach to alert clinicians to this rare cause of gastric ...with 90 Y microspheres without com- ...with 90 Y microspheres, documenting ...
5
Yttrium-90 radioembolization for colorectal cancer liver metastases: a prospective cohort study on circulating angiogenic factors and treatment response
... Background: Yttrium-90 radioembolization ( 90 Y-RE) as a treatment for liver tumours induces radiation damage and hypoxia in liver tissue, which is also a trigger for systemic release of angiogenic ...
12
Yttrium-90 ibritumomab tiuxetan in the treatment of non-Hodgkin lymphoma
... Yttrium-90 (Y90) ibritumomab tiuxetan is an antibody- drug conjugate targeting CD20 and has been investigated as a treatment for NHL in both the front-line and relapsed/ refractory settings. Greater than ...
15
Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments
... Abstract: A selective intra-arterial liver injection using yttrium-90-loaded microspheres as sources for internal radiation therapy is a form of transarterial radioembolization (TARE). Cur- rent data from ...
20
<p>A pooled analysis of transarterial radioembolization with yttrium-90 microspheres for the treatment of unresectable intrahepatic cholangiocarcinoma</p>
... In addition, TARE with 90 Y microspheres is associated with some side effects. In the current pooled analysis, the common clinical toxicities mainly included fatigue, abdominal pain, nausea, vomiting, ascites, and ...
10
Evaluation of the delivered activity of yttrium-90 resin microspheres using sterile water and 5 % glucose during administration
... of 90 Y resin microspheres has evolved worldwide over time with periodic publication of updated guidance [4, ...of 90 Y, two separate published studies have found that stasis neither affected early response ...
7
Post-radioembolization yttrium-90 PET/CT - part 2: dose-response and tumor predictive dosimetry for resin microspheres
... reconstructed 90 Y PET voxels have a spatial reso- lution of approximately 10 to 12 mm at full width at half ...maximum. 90 Y radiation cross fire and beta dose spread were taken to be similar to the ...
12
Computational simulation of the predicted dosimetric impact of adjuvant yttrium-90 PET/CT-guided percutaneous ablation following radioembolization
... The primary endpoint of this effort was successful in elucidating that improvement in unablated tumor dose metrics following adjuvant ablation appear possible; however, the clinical significance of this is unknown. In ...
10
Yttrium 90 microsphere induced gastrointestinal tract ulceration
... he was found to have multiple hepatic metastases and was treated with a course of 5-FU based chemotherapy. Despite aggressive medical therapy, re-staging imaging studies showed a remaining lesion in segment six. He ...
6
Yttrium-90 radioembolization for advanced inoperable hepatocellular carcinoma
... licensed in Hong Kong at the time of publication. After obtaining informed written consent from all of the partici- pants, and reviewing baseline serum hematology, renal and liver biochemistry, alfa-feto protein (AFP) ...
8
Selective intraarterial radionuclide therapy with Yttrium 90 (Y 90) microspheres for unresectable primary and metastatic liver tumors
... ary shunt less than 20% were eligible for therapy. 2 patients were excluded because of the pulmonary shunt higher than 20%. In 78 patients who were suitable for therapy, the Y-90 dose was adjusted according to the ...
8
Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma
... We performed a single-center retrospective analysis of the incidence of adverse events, OS, progression-free survival (PFS), and hepatic or extrahepatic disease PFS following t[r] ...
7
Post-radioembolization yttrium-90 PET/CT - part 1: diagnostic reporting
... noise, 90 Y PET/CT had a higher de- tection rate for non-target activity than 90 Y bremsstrahl- ung ...its 90 Y radioconcentration within the non-target arterial ...
13
Yttrium-90 radioembolization of unresectable hepatocellular carcinoma – a single center experience
... the sequence of treatment options in our cohort, patients had already survived longer after initial diagnosis than they would have without any treatment (time from diagnosis to[r] ...
13
Efficacy of radiosynovectomy in the treatment of chronic knee synovitis: Systematic review and meta-analysis
... Effectiveness of radiation synovectomy with Yttrium-90 and Samarium- 153 particulate hydroxyapatite in rheumatoid arthritis patients with knee synovitis: a controlled, ran[r] ...
6
Radioimmunotherapy-based treatment of cancer
... Randomized controlled trial of yttrium-90- labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-gr[r] ...
9